Health & Technology Law Firm

Providing Excellence in Legal Services to Established Businesses, Emerging Companies and Individual Entrepreneurs

News and Events

Webinar on Protecting IP Rights in Joint Development Agreements - 2015, 2016 2017

Due to incredible demand and high ratings, Strafford Publications asked Sharon Tasman Prysant to present another live session of "Protecting IP Rights in Joint Development Agreements and Strategic Alliances" in 2015, 2016 and 2017.  Included in the presentation were the important topics of:

  • Structuring JDAs to Apportion Contributed, Joint and Derivative IP
  • Planning for Involuntary Early Endings
  • Avoiding Unintended Consequences

Please contact Sharon directly at prysant@healthandtechlaw.com if you would like to arrange a personalized presentation for your organization.


Co-Chair and Panelist at MAGI East 2017

HTLG is pleased to announce that Sharon Tasman Prysant was once again the Co-Chair and Panelist at the recent MAGI East 2017 Clinical Trials Conference in Philadelphia, in May, 2017 for the full day Workshop "Dissecting a Clinical Trial Agreement."

The Workshop was very well received, and Sharon received an "excellent" rating from the attendees.  The Workshop was focused on providing attendees with a working knowledge of all key components of a clinical trial agreement between a clincial trial sponsor and a study site.

Please contact Sharon directly at prysant@healthandtechlaw.com if you would like to receive a copy of the slides.


Co-Chair and Panelist at MAGI East 2016

HTLG is pleased to announce that Sharon Tasman Prysant was a Co-Chair and Panelist at the MAGI East 2016 Clinical Trials Conference in Boston, Massachusetts in May, 2016 for the full day Workshop "Dissecting a Clinical Trial Agreement."

The Workshop was very well received, and was focused on providing attendees with a working knowledge of all key components of a clinical trial agreement between a clincial trial sponsor and a study site.  Topics included regulatory requirements of conducting a clinical trial, intellectual property and confidentiality issues, risk mitigation and study subject injury.

Please contact Sharon directly at prysant@healthandtechlaw.com if you would like to receive a copy of the slides.


Presenter at MAGI West 2015

HTLG is pleased to announce that Sharon Tasman Prysant a presenter at the MAGI West 2015 Clinical Trials Conference in San Diego, California, in October 2015 for the afternoon session of  "Dissecting a Clinical Trial Agreement."

Sharon's presentation was focused on the intellectual property and confidentiality provisions involved in clinical trial agreements between clincial trial sponsors and study sites.

Please contact Sharon directly at prysant@healthandtechlaw.com if you would like to receive a copy of the slides.


Presenter and Session Chair at MAGI East 2014

HTLG is pleased to announce that Sharon Tasman Prysant was a Panelist at the recent MAGI East 2014 Clinical Trials Conference in Philadelphia, May 4-7, 2014 on the topic of "Intellectual Property Provisions in Clinical Trial Agreements."  Sharon also was the Session Chair for "Understanding Your Insurance Policy."

Sharon's session on IP in Clinical Trial Agreements was very well received, and Sharon received an "excellent" rating from the attendees.  The topics presented included a general introduction to intellectual property law (including copyrights, trademarks and trade secrets), a more in-depth discussion of patents and inventions as related to clinical trials, study data and confidentiality, biospecimens and informed consent issues.

Please contact Sharon directly at prysant@healthandtechlaw.com if you would like to receive a copy of the slides.


Webinar on Protecting IP Rights in Joint Development Agreements

HTLG is pleased to announce that Sharon Tasman Prysant presented a program entitled "Protecting IP Rights in Joint Development Agreements and Strategic Alliances" on Thursday, February 20, from 1:00pm-2:30pm EST hosted by Strafford Publications.  Included in the presentation were the important topics of:

  • Structuring JDAs to Apportion Contributed, Joint and Derivative IP
  • Planning for Involuntary Early Endings
  • Avoiding Unintended Consequences

The program was so poplar that it was rebroadcast on May 28, 2014, with Sharon participating in a live question and answer session.  The session is still available for purchase as a recorded Webinar download, audio download, and DVD with slides from Strafford Publications
HERE.




 

View Sharon Tasman Prysant's profile on LinkedIn